“The turning point came when we saw that the proteasome’s peptide-cutting activity changed during infection. That was when we realized we had uncovered a previously unknown immune mechanism.” The ...

This review summarizes the mechanisms of action and clinical ... immunomodulatory drugs (IMiDs) and the proteasome inhibitor bortezomib. [1] IMiDs are structural and functional analogs of ...